Cleo’s Chief Executive Officer, Richard Allman and Chief Scientific Officer, Andrew Stephens, provide an update on the Company’s progress and commercialisation pathway.
Cleo Investor Webinar - an update on the Company’s progress and commercialisation pathway
Previous
Previous
CLEO Strengthens FDA Submission Following Access to Globally Respected U.S. Biobank
Next
Next